Jennifer Porcelli
Investor Relations Contact chez BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
Jennifer Porcelli is currently working as the Vice President of Investor Relations at Biohaven Pharmaceutical Holding Co. Ltd.
and Biohaven Ltd.
She previously held positions as the Managing Director at Solebury Strategic Communications LLC and as the Head of Investor Relations at Centessa Pharmaceuticals LLC.
Ms. Porcelli completed her undergraduate degree at Georgetown University.
Postes actifs de Jennifer Porcelli
Sociétés | Poste | Début |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Investor Relations Contact | 01/01/2022 |
BIOHAVEN LTD. | Investor Relations Contact | 01/02/2022 |
Anciens postes connus de Jennifer Porcelli
Sociétés | Poste | Fin |
---|---|---|
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Corporate Officer/Principal | - |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Investor Relations Contact | - |
Formation de Jennifer Porcelli
Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOHAVEN LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Commercial Services |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Health Technology |